Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Express Scripts
Deloitte
McKesson
Fish and Richardson
AstraZeneca

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 10,154,813

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,154,813
Title:Method and apparatus for patient skin color monitoring and drug efficacy measurement
Abstract: Methods and apparatus for determining the efficacy of a drug by diagnosing cardiovascular health in a patient by monitoring changes in skin redness levels, which is associated with perfusion and ability of circulatory system to adapt to physical exertion. Color detectors including colorimeters and spectrophotometers may be used to monitor and quantify skin color. Wet run solutions such as acetylcholine solutions may be applied to the skin area being monitored. Skin redness can be monitored during the course of exercise or a stress test, as well as during recovery. Wearable color detector devices can be worn by patients during exercise.
Inventor(s): Kokolis; Spyros (Brooklyn, NY)
Assignee:
Application Number:16/015,057
Patent Claims:see list of patent claims

Details for Patent 10,154,813

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 002 2017-04-24 ➤ Sign Up ➤ Sign Up RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24 ➤ Sign Up ➤ Sign Up RX search
Amgen Inc REPATHA evolocumab INJECTABLE;INJECTION 125522 001 2016-07-08 ➤ Sign Up ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
US Department of Justice
Fuji
Mallinckrodt
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.